No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
DXCM241213P59000
- 0.00
- 0.000.00%
15min DelayTrading Dec 11 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest59.00Strike Price0.00Turnover0.00%IV26.56%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma401.70Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
DexCom Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $94
Express News | Dexcom Inc : Citigroup Raises Target Price to $91 From $85
Express News | Dexcom, Inc. : Wells Fargo Raises Target Price to $94 From $90
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Dexcom Shares up as Diabetes Association Updates Guidelines